IN201641043301A - - Google Patents
Info
- Publication number
- IN201641043301A IN201641043301A IN201641043301A IN201641043301A IN201641043301A IN 201641043301 A IN201641043301 A IN 201641043301A IN 201641043301 A IN201641043301 A IN 201641043301A IN 201641043301 A IN201641043301 A IN 201641043301A IN 201641043301 A IN201641043301 A IN 201641043301A
- Authority
- IN
- India
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201641043301A IN201641043301A (en) | 2016-12-19 | 2016-12-19 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201641043301A IN201641043301A (en) | 2016-12-19 | 2016-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN201641043301A true IN201641043301A (en) | 2018-06-22 |
Family
ID=75714404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN201641043301A IN201641043301A (en) | 2016-12-19 | 2016-12-19 |
Country Status (1)
Country | Link |
---|---|
IN (1) | IN201641043301A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111205224A (en) * | 2020-04-22 | 2020-05-29 | 南京佰麦生物技术有限公司 | Crystal form of roxasistat hydrate, and preparation method and application thereof |
WO2021077994A1 (en) | 2019-10-22 | 2021-04-29 | 苏州科睿思制药有限公司 | Crystal form of hypoxia-inducible factor-prolyl hydroxylase inhibitor |
CN113956200A (en) * | 2021-12-16 | 2022-01-21 | 南京威凯尔生物医药科技有限公司 | Crystallization process of roxasistat bulk drug with controlled particle size |
-
2016
- 2016-12-19 IN IN201641043301A patent/IN201641043301A/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021077994A1 (en) | 2019-10-22 | 2021-04-29 | 苏州科睿思制药有限公司 | Crystal form of hypoxia-inducible factor-prolyl hydroxylase inhibitor |
CN111205224A (en) * | 2020-04-22 | 2020-05-29 | 南京佰麦生物技术有限公司 | Crystal form of roxasistat hydrate, and preparation method and application thereof |
CN113956200A (en) * | 2021-12-16 | 2022-01-21 | 南京威凯尔生物医药科技有限公司 | Crystallization process of roxasistat bulk drug with controlled particle size |